A national analysis of US ambulatory care visits finds patients with psoriasis have more than eightfold increased odds of ...

Everyday Health shares their favorite psoriasis organizations to help you educate yourself, spread awareness, and connect ...

While TB and meningitis are rare among patients receiving systemic psoriasis therapies, IL-17 inhibitors increase the risk for candidiasis.

Since the drug’s approval and launch earlier this year, J&J has recorded more than 20,000 patient starts on Icotyde, funneled ...

Whether you’re managing just psoriatic arthritis or both psoriatic arthritis and psoriasis, it helps to have an arsenal of information at your fingertips. For advice about which medications to try, ...

“Accept that this is part of you, own it, and don’t let it stop you from achieving your goals.” ...

Patients with moderate to severe plaque psoriasis who received any dosage of SHR-1139 had improvements in skin clearance at ...

Zasocitinib demonstrated superiority over deucravacitinib for the treatment of moderate to severe plaque psoriasis, according ...

Multi-country discrete-choice experiment presented at the Fall Clinical Dermatology Conference demonstrates that skin ...

The combination of medications also showed increased inflammatory immune activity compared with Taltz alone.

Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

A new study finds that AI systems and large language models achieve at best 25 percent accuracy in diagnosing psoriasis in ...